Submitted by Sabin on
NEW CANAAN, CT, JUNE 29, 2005 —The Sabin Vaccine Institute will recognize extraordinary contributors to disease research and healthcare innovations at its black-tie gala beginning at 6:30 p.m. on June 29, 2005 at the University Club in New York City.
Submitted by Sabin on
NEW CANAAN, CT— Albert Z. Kapikian, MD, physician, medical pioneer and viral diseases researcher, received the prestigious Albert B. Sabin Gold Medal at a ceremony on May 10, 2005. Kapikian is the 13th recipient of this recognition, awarded annually by the Sabin Vaccine Institute to honor achievements by vaccinologists and infectious disease experts.
Submitted by Sabin on
July 7, 2004
Submitted by Sabin on
COLD SPRING HARBOR, NY — Health experts wrapped up a meeting here Tuesday to formulate recommendations for vaccine policy in the event of a pandemic flu outbreak. The group acknowledges that routine annual influenza epidemics would be overshadowed by the looming calamity posed by a pandemic influenza event.
Submitted by Sabin on
NEW CANAAN, CT —Recent highly publicized vaccine shortages have cast a shadow over the otherwise enormous success of vaccines as a tool for disease prevention around the world. Vaccines have been the cornerstone of public health for the past 50 years and shortages have shaken public confidence and exposed real vulnerabilities in the current system of vaccines production.
Submitted by Sabin on
Mexico City, July 7, 2004 (PAHO)—Rotavirus "is a major, major public health priority" for Mexico and for the Americas, Mexican Health Minister Dr. Julio Frenk said today at the opening of a global symposium on rotavirus, where health experts will spend three days discussing the latest information about the deadly disease.
Submitted by Sabin on
NEW CANAAN, CT—The Sabin Vaccine Institute will celebrate a Salute to Life-Saving Discoveries during its benefit dinner at The Pierre Hotel in New York City May 12. The evening will feature the presentation of awards to Nobel laureate James D. Watson, PhD, and to Howard Pien, president and CEO of Chiron Corporation.
Submitted by Sabin on
NEW CANAAN, Conn., April 27 — Fifty years ago, six-year-old Randy Kerr from McLean, Virginia, was officially designated the nation's first child to be vaccinated with an experimental polio vaccine developed by Jonas Salk in his University of Pittsburgh laboratory. Over the next several months thousands of children who became known as "Polio Pioneers" stepped up to receive their polio injections as part of an enormous vaccine field trial.
Submitted by Sabin on
NEW CANAAN, CT, April 26, 2004—As “Vaccination Week” in the Americas unfolds this week, the Sabin Vaccine Institute joins with the international sponsors in declaring the need for a reduction in immunization inequities among children and women who have never been vaccinated. The week of community awareness activities and national immunization campaigns opened April 24 with a regional launch in the small village of Fond Parisien, Haiti, where local children received life-saving vaccinations.
Submitted by Sabin on
NEW CANAAN, CT, April 7, 2004—The regulation of cancer vaccines by the U.S. Food and Drug Administration (FDA) and European Union offers both opportunities and potential pitfalls for industry and research, according to speakers at last week’s meeting of the Cancer Vaccine Consortium (CVC), “Federal Regulation and Cancer Vaccines.” As part of the meeting, the CVC launched two new working groups to address regulatory issues and engage the FDA in policy discussions.
